Table 1.

Oligonucleotide primers used in this study

Primer namePrimer sequenceProduct size (bp)Reference or sourcea
EASTa5′-GAAGTTCTGGCTCAATGCGC-3′172This study
EASTb5′GAAGTTCTGGCTCAATGCGC-3′
LIFa5′-GAGGCGCTGAAGATCAAACA-3′330This study
LIFb5′-TGTATTATCAGGAGGTGCGC-3′
ESPPa5′-AAACAGCAGGCACTTGAACG-3′301This study
ESPPb5′-AGACAGTTCCAGCGACAACC-3′
EspP5′5′GGTTGATTCCTGCGGGACG-3′
EhxA5′ACGATGTGGTTTATTCTGGA-3′16520
EhxB5′CTTCACGTGACCATACATAT-3′
StxA5′GAAGGAAATAATTTATATGT-3′Various4
StxB5′TTTGATTGTTACAGTCAT-3′
EacAa5′ACAAACTTTGGGATGTTC-3′55022
EacAb5′ACAAACTTTGGGATGTTC-3′
EspAa5′CACGTCTTGAGGAAGTTTGG-3′299This study
EspAb5′CCGTTGTTAATGTGAGTGCG-3′
EspBa5′CGATGGTTAATTCCGCTTCG-3′304This study
EspBb5′GCCTGCTGAATCTGATAGCT-3′
FimA5′GCCGGATTATGGGAAAGA-3′60031
FimB5′GCCGCTGTAGAACTGAGGG-3′
F4a5′GGTGATTTCAATGGTTCGGTC-3′76422
F4b5′AATGCTACGTTCAGCGGAGCG-3′
F5a5′TATTATCTTAGGTGGTATGG-3′31422
F5b5′GGTATCCTTTAGCAGCAGTATTTC-3′
F17A5′GCAGAAAATTCAATTTATCCTTGG-3′5376
F17B5′CTGATAAGCGATGGTGTAATTAAC-3′
F41A5′GCATCAGCGGCAGTATCT-3′38022
F41B5′GTCCCTAGCTCAGTATTATGACCT-3′
F107A5′GTGAAAAGACTAGTGTTTATTTC-3′51022
F107B5′CTTGTAAGTAACCGCGTAAGC-3′
SfamA5′CTCCGGAGAACTGGGTGCATCTTAC-3′420IMBID
SfamB5′CGGAGGAGTAATTACAAACCTGGCA-3′
pap15′GACGGCTGTACTGCAGGGTGTGGCG-3′430IMBID
pap25′ATATCCTTTCTGCAGGGATGCAATA-3′
  • a IMBID, Institute for the Molecular Biology of Infectious Disease, Wurzburg, Germany.